VEGFA and miotic rate: It has been reported that various antiangiogenic agents, such as VEGF antibodies (Bevacizumab) and tyrosinkinase inhibitors (Sunitinib), can also cause jaw necrosis and therefore the development of MR-ONJ [37,38].